SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
JinwenShi
Lv3
250 积分
2023-03-16 加入
最近求助
最近应助
互助留言
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
9天前
已完结
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
9天前
已完结
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling
2个月前
已完结
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
3个月前
已完结
Cytokine Release Syndrome Biology and Management
4个月前
已完结
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study
4个月前
已完结
Dermatomyositis: Diagnosis and treatment
5个月前
已完结
Baricitinib for the treatment of cutaneous dermatomyositis: A prospective, open-label study
5个月前
已完结
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
7个月前
已完结
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
7个月前
已完结
没有进行任何应助
感谢,点赞
3个月前
您好,可以再帮忙上传一下这篇文献的附件嘛?谢谢!
4个月前
请问是否有正式接收完成排版的文件?
5个月前
感谢,点赞
5个月前
感谢,点赞
7个月前
感谢,点赞
7个月前
感谢,点赞
7个月前
帮大忙了,谢谢~
8个月前
不感兴趣了【积分已退回】
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论